Free Trial

Talis Biomedical (TLIS) Competitors

Talis Biomedical logo
$1.41 +0.16 (+12.80%)
As of 07/24/2025 09:42 AM Eastern

TLIS vs. TBIO, SMIT, SPEC, THMO, HTGMQ, OLITW, PRENW, QSIAW, SMAPW, and TT

Should you be buying Talis Biomedical stock or one of its competitors? The main competitors of Talis Biomedical include Telesis Bio (TBIO), Schmitt Industries (SMIT), Spectaire (SPEC), ThermoGenesis (THMO), HTG Molecular Diagnostics (HTGMQ), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), Quantum-Si (QSIAW), SportsMap Tech Acquisition (SMAPW), and Trane Technologies (TT). These companies are all part of the "measuring and control equipment" industry.

Talis Biomedical vs. Its Competitors

Telesis Bio (NASDAQ:TBIO) and Talis Biomedical (NASDAQ:TLIS) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, media sentiment, analyst recommendations, institutional ownership, dividends, valuation and profitability.

Talis Biomedical has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%. Telesis Bio's return on equity of 0.00% beat Talis Biomedical's return on equity.

Company Net Margins Return on Equity Return on Assets
Telesis Bio-336.59% N/A -61.89%
Talis Biomedical N/A -79.74%-57.16%

37.6% of Telesis Bio shares are held by institutional investors. Comparatively, 43.8% of Talis Biomedical shares are held by institutional investors. 24.5% of Telesis Bio shares are held by insiders. Comparatively, 46.0% of Talis Biomedical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Telesis Bio's average media sentiment score of 0.00 equaled Talis Biomedical'saverage media sentiment score.

Company Overall Sentiment
Telesis Bio Neutral
Talis Biomedical Neutral

Telesis Bio has a beta of 2.89, indicating that its share price is 189% more volatile than the S&P 500. Comparatively, Talis Biomedical has a beta of 1.29, indicating that its share price is 29% more volatile than the S&P 500.

Telesis Bio has higher revenue and earnings than Talis Biomedical. Talis Biomedical is trading at a lower price-to-earnings ratio than Telesis Bio, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Telesis Bio$225.09M0.00-$47.72M-$28.200.00
Talis Biomedical$300K8.57-$62.01M-$28.02-0.05

Summary

Talis Biomedical beats Telesis Bio on 6 of the 11 factors compared between the two stocks.

Get Talis Biomedical News Delivered to You Automatically

Sign up to receive the latest news and ratings for TLIS and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLIS vs. The Competition

MetricTalis BiomedicalAnalytical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$2.57M$1.31M$5.69B$9.50B
Dividend YieldN/AN/A4.58%4.01%
P/E Ratio-0.05N/A28.1020.05
Price / Sales8.574.28432.4890.19
Price / CashN/AN/A36.2258.56
Price / Book0.040.108.665.87
Net Income-$62.01M-$54.87M$3.25B$258.55M
7 Day Performance12.80%12.80%4.22%3.73%
1 Month Performance-1.40%-1.40%10.51%11.75%
1 Year Performance-83.07%-83.07%34.40%18.03%

Talis Biomedical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TLIS
Talis Biomedical
N/A$1.41
+12.8%
N/A-83.7%$2.57M$300K-0.05260Gap Up
TBIO
Telesis Bio
N/A$0.05
+105.8%
N/A-99.4%$90K$225.09M0.00200Gap Up
SMIT
Schmitt Industries
N/A$0.02
flat
N/AN/A$82K$9.89M0.00160
SPEC
Spectaire
N/A$0.00
+50.0%
N/A-99.9%$6KN/A0.008Gap Up
THMO
ThermoGenesis
N/AN/AN/AN/A$1K$9.61M0.0040
HTGMQ
HTG Molecular Diagnostics
N/AN/AN/AN/A$0.00$6.37M0.0090
OLITW
OmniLit Acquisition
N/A$0.09
+15.1%
N/A-22.6%$0.00N/A0.003High Trading Volume
PRENW
Prenetics Global
N/A$0.03
-27.2%
N/A+169.8%$0.00$41.52M0.001Positive News
Gap Down
QSIAW
Quantum-Si
N/A$0.60
+0.0%
N/AN/A$0.00$3.44M0.00150Positive News
SMAPW
SportsMap Tech Acquisition
N/A$0.04
-2.8%
N/A+81.8%$0.00N/A0.00N/AGap Down
TT
Trane Technologies
4.5128 of 5 stars
$443.47
+0.2%
$441.40
-0.5%
+46.6%$98.96B$19.84B36.9245,000Positive News
Upcoming Earnings

Related Companies and Tools


This page (NASDAQ:TLIS) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners